Dental implantology has entered a new era with the introduction of SinusFuse, a groundbreaking innovation recognized as the world’s first true sinus implant. Designed to address one of the most complex challenges in implant dentistry—insufficient bone height in the posterior maxilla—SinusFuse represents a major technological leap, combining advanced biomechanics, minimally invasive principles, and patented engineering into a single implant system.

Developed under the OsseoFuse Dental Implant System, SinusFuse is not merely an incremental improvement. It is a paradigm shift that redefines how clinicians approach sinus elevation, bone management, and implant placement in compromised maxillary cases.

The Clinical Challenge of Maxillary Sinus Implants

Posterior maxillary implant placement is often complicated by pneumatization of the maxillary sinus and reduced residual bone height following tooth loss. Traditionally, these cases require additional surgical interventions such as lateral window sinus lifts or crestal sinus elevation with grafting materials. While effective, these procedures increase treatment time, cost, patient morbidity, and clinical risk.

SinusFuse was engineered specifically to overcome these limitations by integrating sinus elevation and implant placement into a single, controlled, minimally invasive procedure.

What Is SinusFuse?

SinusFuse is a patented sinus implant within the OsseoFuse Dental Implant System. It is manufactured from high-grade biocompatible titanium and titanium alloys, ensuring excellent osseointegration, mechanical strength, and long-term stability.

Unlike conventional implants, SinusFuse is designed to interact dynamically with the sinus floor. During placement, it performs multiple critical functions simultaneously:

• Controlled up-fracture of the sinus floor

• Harvesting and transporting autogenous bone

• Gentle elevation of the Schneiderian membrane

• Immediate implant placement in a single surgical sequence

This integrated functionality eliminates the need for separate sinus lift instruments or grafting procedures in many clinical scenarios.

OsseoFuse Dental Implant System Overview

The OsseoFuse system includes HexaPlus™, ConicalPlus™, and Sinus™ implants, along with compatible abutments, overdenture bars, and restorative components. The system is indicated for use in both the maxilla and mandible, supporting:

• Single-tooth restorations

• Multiple-unit prostheses

• Cement-retained and screw-retained restorations

• Overdentures

• Fixed bridgework (terminal or intermediate abutments)

The system supports one-stage and two-stage surgical protocols and is intended primarily for delayed loading, allowing predictable osseointegration in a wide range of bone qualities.

Indications for SinusFuse and OsseoFuse Implants

SinusFuse and other OsseoFuse implants are indicated for patients who are partially or fully edentulous, provided adequate bone conditions exist. Minimum bone requirements include:

• At least 1 mm of circumferential bone

• At least 2 mm of apical bone

They are suitable for cases where traditional implant placement would otherwise require sinus augmentation procedures.

Surgical Planning and Directions for Use

Successful outcomes with SinusFuse rely heavily on proper diagnosis, planning, and surgical execution. Before implant placement, clinicians must evaluate:

• Vertical dimension and restorative space

• Distance between the alveolar crest and opposing dentition

• Abutment selection and final prosthetic design

Importantly, the final prosthesis should be planned before implant placement to ensure restorative-driven implant positioning.

During surgery, continuous sterile irrigation is mandatory to prevent thermal trauma and protect surrounding tissues. Excessive drilling pressure must be avoided, and only sharp, high-quality instruments should be used to preserve bone vitality and enhance osseointegration.

Contraindications and Patient Selection

SinusFuse implants should not be placed in patients with:

• Severely insufficient bone volume or density

• Poor oral hygiene

• Heavy tobacco use

• Uncontrolled systemic conditions such as diabetes or blood disorders

Inadequate patient selection or compromised bone conditions significantly increase the risk of implant failure or lack of osseointegration.

Warnings and Precautions

Dental implant surgery is a highly specialized clinical procedure. Proper training in implantology is strongly recommended before using the OsseoFuse system. Incorrect technique may lead to implant instability, excessive bone loss, or restoration failure.

Additional precautions include:

• Avoiding electrosurgical devices or lasers near metallic implants

• Monitoring for signs of implant mobility, infection, or bone loss

• Immediate intervention or removal if implant failure is suspected

• Preventing aspiration or swallowing of small components

• Avoiding small-diameter implants with angled abutments in posterior regions

The OsseoFuse system has not been evaluated for MRI safety, and compatibility in MR environments has not been established.

Sterility, Cleaning, and Instrument Handling

OsseoFuse implant fixtures, mounts, and cover screws are supplied sterile via gamma irradiation and are ready for use. Abutments, accessories, and surgical instruments are provided non-sterile and must be sterilized before use.

Recommended cleaning protocol includes:

1. Ultrasonic cleaning for 10 minutes

2. Manual removal of debris with a soft-bristle brush

3. Thorough rinsing, including an alcohol rinse to prevent corrosion

4. Complete air drying

5. Steam sterilization using validated cycles

These sterilization parameters are validated to a Sterility Assurance Level (SAL) of 10⁻⁶ in accordance with FDA-recognized ISO standards.

Healing, Restoration, and Occlusal Considerations

Healing time varies based on bone quality, tissue response, and surgical assessment. During this period, excessive functional loading must be avoided. Proper occlusal design is essential to prevent overload, which can compromise osseointegration and long-term implant success.

Potential Adverse Events

As with any implant system, potential complications may include:

• Failure or loss of osseointegration

• Bone dehiscence requiring grafting

• Sinus or anatomical structure perforation

• Infection, abscess, or inflammation

• Persistent pain or altered sensation

• Excessive bone loss

• Implant fracture

Early diagnosis and intervention are critical to managing these risks effectively.

The Innovator Behind SinusFuse: Dr. C. Leon Chen

Meet the Innovator Behind SinusFuse: Dr. C. Leon Chen

The vision behind SinusFuse belongs to Dr. C. Leon Chen, DMD, MS, DBA, a globally respected authority in implant dentistry and minimally invasive techniques. A graduate of Harvard University School of Dental Medicine and Northwestern University’s Department of Periodontics, Dr. Chen has dedicated over three decades to advancing implant science.

He is the inventor of the Hydraulic Sinus Condensing (HSC) Technique, widely regarded as a gold standard for minimally invasive sinus elevation. In the mid-1990s, he pioneered the use of hydraulic pressure to access the sinus safely without membrane perforation—an innovation that laid the foundation for SinusFuse.

Dr. Chen has also introduced numerous landmark techniques, including flapless sinus lifts, immediate loading protocols, vertical and lingual augmentation methods, and AI-driven implant planning software. He holds over 50 international patents and trademarks and has received multiple innovation awards, including gold medals at the INPEX Medical Innovation Conference.

As co-founder of the Dental Implant Institute in Las Vegas, Dr. Chen continues to educate clinicians worldwide while shaping the future of precision, nano-invasive implant dentistry.

Conclusion: A New Standard in Sinus Implantology

SinusFuse is more than an implant—it is a comprehensive clinical solution. By integrating sinus elevation, bone management, and implant placement into a single procedure, it reduces surgical complexity, shortens treatment time, and improves patient comfort.

As the world’s first sinus implant, SinusFuse sets a new benchmark for innovation in dental implantology, reflecting a future where advanced engineering and minimally invasive dentistry work seamlessly together to achieve superior clinical outcomes.

Frequently Asked Questions (FAQ) About SinusFuse

1. What makes SinusFuse different from conventional dental implants?
SinusFuse is the world’s first implant specifically engineered to function as a sinus implant. Unlike conventional implants, it integrates multiple surgical steps into one procedure by controlled up-fracturing of the sinus floor, transporting autogenous bone, gently elevating the sinus membrane, and placing the implant simultaneously. This reduces the need for separate sinus lift surgeries.

2. In which clinical situations is SinusFuse most commonly indicated?
SinusFuse is primarily indicated for posterior maxillary cases with limited residual bone height where traditional implants would require sinus augmentation. It is suitable for partially or fully edentulous patients who meet the minimum bone requirements and are candidates for delayed loading protocols.

3. Does SinusFuse eliminate the need for bone grafting materials?
In many cases, yes. SinusFuse is designed to harvest and reposition the patient’s own autogenous bone during placement, which can significantly reduce or eliminate the need for additional grafting materials. However, final clinical decisions depend on individual anatomy and bone quality.

4. Is SinusFuse compatible with standard prosthetic restorations?
Yes. SinusFuse is part of the OsseoFuse Dental Implant System and is compatible with a wide range of prosthetic options, including cement-retained, screw-retained, overdenture, and fixed bridge restorations, provided proper treatment planning is performed.

5. What level of training is required to use SinusFuse safely?
SinusFuse should only be used by clinicians who have received formal training in implant dentistry. Due to its advanced design and specialized surgical protocol, additional education in minimally invasive sinus techniques is strongly recommended to ensure predictable outcomes and minimize complications.

6. What are the main risks associated with SinusFuse implantation?
As with any implant system, potential risks include lack of osseointegration, infection, excessive bone loss, sinus membrane perforation, or implant failure. Proper patient selection, precise surgical technique, and adherence to clinical protocols significantly reduce these risks.

7. How much height can be predictably obtained?

Crestal sinus lift ranges from ~3–5 mm under ideal conditions.

8. What is the minimum horizontal width and vertical height from the alveolar crest to the sinus to securely lift the membrane?

A minimum residual bone height (RBH) of ~2 mm above the sinus floor. Minimum horizontal width >4mm.